Access

You are not currently logged in.

Access your personal account or get JSTOR access through your library or other institution:

login

Log in to your personal account or through your institution.

If You Use a Screen Reader

This content is available through Read Online (Free) program, which relies on page scans. Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.

Impact of age and sex on primary preventive treatment for cardiovascular disease in the West Midlands, UK: cross sectional study

J P Sheppard, S Singh, K Fletcher, R J McManus and J Mant
BMJ: British Medical Journal
Vol. 345, No. 7866 (21 July 2012), p. 17
Published by: BMJ
Stable URL: http://www.jstor.org/stable/23278351
Page Count: 1
  • Read Online (Free)
  • Subscribe ($19.50)
  • Cite this Item
Since scans are not currently available to screen readers, please contact JSTOR User Support for access. We'll provide a PDF copy for your screen reader.
Preview not available
Preview not available

Abstract

STUDY QUESTION What is the impact of age and sex on prescription of antihypertensive drugs and statins for primary prevention of cardiovascular disease in primary care? SUMMARY ANSWER While prescription of antihypertensive drugs increased with age, the use of statins declined in people aged ≥74, despite their increased risk of cardiovascular disease. Previously described undertreatment of women in secondary prevention of cardiovascular disease was not observed for primary prevention. WHAT IS KNOWN AND WHAT THIS PAPER ADDS Age inequalities exist in prescription of statins in elderly patients with existing cardiovascular disease. These inequalities also exist in those eligible for primary preventive treatment, in whom prescribing trends for statins seem to closely follow guidelines, which do not offer clear guidance for elderly patients.

Page Thumbnails

  • Thumbnail: Page 
17
    17